Skip to main content

NVE CORP /NEW/ (NVEC) Stock Forecast 2025 - AI Price Prediction & Analysis


NVE CORP /NEW/ (NVEC) AI Stock Price Forecast & Investment Analysis

NVE CORP /NEW/ Stock Price Chart and Technical Analysis

Loading NVE CORP /NEW/ interactive price chart and technical analysis...

NVE CORP /NEW/ (NVEC) - Comprehensive Stock Analysis & Investment Research

Deep dive into NVE CORP /NEW/'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about NVE CORP /NEW/, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For NVE CORP /NEW/: NVE CORP /NEW/ operates in the Manufacturing sector, making it an emerging small-cap investment.

NVE CORP /NEW/ (Stock Symbol: NVEC) is a leading company in the Manufacturing sector , specifically operating within the Semiconductors & Related Devices industry.

The organization employs approximately 37 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing NVE CORP /NEW/'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NVE CORP /NEW/: With $24M in annual revenue and 41.9% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $24 million generating a 41.9% net profit margin .

Market Capitalization: $348 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): 21.4% - Exceptional shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for NVE CORP /NEW/ stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For NVE CORP /NEW/: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for NVE CORP /NEW/ stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: NVE CORP /NEW/'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For NVE CORP /NEW/: Strong free cash flow generation demonstrates developing operational efficiency.

NVE CORP /NEW/ strategically competes in the highly dynamic Semiconductors & Related Devices marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $12 million annually, complemented by impressive -15.9% year-over-year cash flow growth.

The company maintains a healthy 68.4% gross margin, indicating strong pricing power and operational efficiency.

NVE CORP /NEW/ (NVEC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for NVE CORP /NEW/ stock analysis.

Loading NVE CORP /NEW/ comprehensive fundamental analysis and insider trading data...

Deep dive into NVE CORP /NEW/'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if NVE CORP /NEW/ stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For NVE CORP /NEW/: With a P/E ratio of 25.46, the market highly values future growth prospects.

P/E Ratio 25.46x
P/B Ratio 5.83x
Market Cap $348M
Dividend Yield 5.50%
EPS $2.86
Book Value/Share $12.34
Revenue/Share $5.12
FCF/Share $2.45
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently NVE CORP /NEW/ converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For NVE CORP /NEW/: An ROE of 21.4% demonstrates excellent shareholder value creation.

ROE 21.4%
ROA 20.7%
ROIC 19.8%
Gross Margin 68.4%
Operating Margin 54.9%
Net Margin 41.9%
EBT Margin 64.9%
Tax Rate 17.1%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess NVE CORP /NEW/'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For NVE CORP /NEW/: A current ratio of 16.90 indicates strong liquidity.

Current Ratio 16.90x
Quick Ratio 14.65x
D/E Ratio 0.01x
Financial Leverage 1.04x
Working Capital $23M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal NVE CORP /NEW/'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For NVE CORP /NEW/: Free cash flow of $12M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $13M
Free Cash Flow $12M
OCF Growth YoY -15.9%
FCF Growth YoY -16.0%
FCF/Sales 44.5%
CapEx/Sales 1.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively NVE CORP /NEW/ uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For NVE CORP /NEW/: An asset turnover of 0.39x suggests room for improvement in asset utilization.

Asset Turnover 0.39x
Receivables Turnover 8.1x
Inventory Turnover 1.4x
Fixed Assets Turnover 24.6x
Days Sales Outstanding 45 days
Days Inventory 262 days
Payables Period 37 days
Cash Conversion Cycle 270 days
Understanding Financial Statement Data

What these metrics mean: Key figures from NVE CORP /NEW/'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For NVE CORP /NEW/: With annual revenue of $24M, NVE CORP /NEW/ represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $24M
Operating Income $18M
Net Income $13M
R&D Expense $2M
SG&A Expense $5M
Cost of Goods Sold $23M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 62%
Cash & Short-term Investments 46%
Total Liabilities 4%
Accounts Receivable 7%
Inventory 8%
Dividend & Shareholder Information
Dividends Per Share $4.00
Payout Ratio 1.4%
Shares Outstanding 5M
Growth Metrics (YoY)
EPS Growth 3.9%

Latest NVE CORP /NEW/ Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting NVE CORP /NEW/ (NVEC) stock price and investment outlook.

, source: Yahoo Finance

Earnings call NVE reported a 5% YoY revenue decline in Q2 FY25 due to weak product sales, but improved gross margin to 86% from 78% on favorable mix. EPS was $0.83, with strong profitability driven by ...

, source: None

Tuesday, October 28, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp ...

, source: Chron

EDEN PRAIRIE, Minn. (AP) — EDEN PRAIRIE, Minn. (AP) — NVE Corp. (NVEC) on Wednesday reported net income of $3.3 million in its fiscal second quarter. On a per-share basis, the Eden Prairie, ...

, source: MarketWatch

NEW YORK (CBS.MW) -- NVE Corp. shares rallied more than 10 percent to $24.67 after the company said its founder James Daughton has completed the sale of 213,700 of its common shares. Daughton, who ...

, source: Yahoo Finance

Earnings call NVE reported a 3% YoY and 44% QoQ revenue increase in Q4 FY2025, with net income up 2% YoY. Gross margins expanded to 79% in the quarter and 84% for the year. Management is investing ...

NVE CORP /NEW/ Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of NVE CORP /NEW/ against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAOI Unlock Forecast - 30 Days FREE Trial $2196M -17.5x 5.2x
ADI Unlock Forecast - 30 Days FREE Trial $115629M 61.1x 3.4x
ADTTF Unlock Forecast - 30 Days FREE Trial $20806M x 0.2x
AIP Unlock Forecast - 30 Days FREE Trial $569M -10.4x -85.5x
ALAB Unlock Forecast - 30 Days FREE Trial $28858M 280.8x 25.4x
ALGM Unlock Forecast - 30 Days FREE Trial $5685M 73.8x 6.2x
ALMU Unlock Forecast - 30 Days FREE Trial $254M x 14.2x
AMAT Unlock Forecast - 30 Days FREE Trial $191193M 27.1x 9.8x
AMBA Unlock Forecast - 30 Days FREE Trial $3670M -17.3x 6.4x
AMD Unlock Forecast - 30 Days FREE Trial $428743M 144.8x 7.2x
AMKR Unlock Forecast - 30 Days FREE Trial $8081M 25.0x 1.9x
AOSL Unlock Forecast - 30 Days FREE Trial $846M -88.3x 1.0x
ARM Unlock Forecast - 30 Days FREE Trial $180443M 298.0x 25.8x
ATEYY Unlock Forecast - 30 Days FREE Trial $24744M x 0.2x
ATOM Unlock Forecast - 30 Days FREE Trial $98M -3.5x 4.6x
AVGO Unlock Forecast - 30 Days FREE Trial $1822598M 88.3x 73.1x
AXTI Unlock Forecast - 30 Days FREE Trial $326M -7.3x 1.8x
BZAI Unlock Forecast - 30 Days FREE Trial $378M x 29.3x
CRDO Unlock Forecast - 30 Days FREE Trial $29655M 220.2x 38.0x
CRUS Unlock Forecast - 30 Days FREE Trial $7001M 19.9x 3.6x
DIOD Unlock Forecast - 30 Days FREE Trial $2517M 41.4x 1.3x
DQ Unlock Forecast - 30 Days FREE Trial $11355M x 5.3x
ENPH Unlock Forecast - 30 Days FREE Trial $4075M 27.2x 4.1x
FORM Unlock Forecast - 30 Days FREE Trial $3680M 75.8x 3.7x
FSLR Unlock Forecast - 30 Days FREE Trial $25923M 20.4x 3.0x
FTCI Unlock Forecast - 30 Days FREE Trial $131M -8.3x 14.5x
GCTS Unlock Forecast - 30 Days FREE Trial $82M x -1.2x
GSIT Unlock Forecast - 30 Days FREE Trial $269M -4.5x 7.2x
GUER Unlock Forecast - 30 Days FREE Trial $12M x x
HIMX Unlock Forecast - 30 Days FREE Trial $3277M x 7.2x
HYSR Unlock Forecast - 30 Days FREE Trial $205M x 5.6x
ICG Unlock Forecast - 30 Days FREE Trial $179M x 1.3x
ICHR Unlock Forecast - 30 Days FREE Trial $786M -30.4x 1.1x
INDI Unlock Forecast - 30 Days FREE Trial $1069M -8.3x 2.7x
INTC Unlock Forecast - 30 Days FREE Trial $180077M -6.2x 1.8x
IPGP Unlock Forecast - 30 Days FREE Trial $3656M -756.9x 1.7x
IPWR Unlock Forecast - 30 Days FREE Trial $49M -5.9x 3.8x
JKS Unlock Forecast - 30 Days FREE Trial $4265M x 0.4x
KLIC Unlock Forecast - 30 Days FREE Trial $2080M 348.5x 2.5x
LAES Unlock Forecast - 30 Days FREE Trial $848M x 7.2x
LASR Unlock Forecast - 30 Days FREE Trial $1589M -10.7x 7.4x
LEDS Unlock Forecast - 30 Days FREE Trial $19M -3.6x 4.7x
LPTH Unlock Forecast - 30 Days FREE Trial $351M -8.8x 22.4x
LSCC Unlock Forecast - 30 Days FREE Trial $10097M 301.1x 14.7x
MAXN Unlock Forecast - 30 Days FREE Trial $157M x 3.7x
MCHP Unlock Forecast - 30 Days FREE Trial $33751M 28.8x 4.9x
MCHPP Unlock Forecast - 30 Days FREE Trial $32564M x 4.8x
MOBX Unlock Forecast - 30 Days FREE Trial $35M x 82.7x
MPWR Unlock Forecast - 30 Days FREE Trial $52398M 27.6x 15.4x
MRAM Unlock Forecast - 30 Days FREE Trial $240M 145.4x 3.7x
MRVL Unlock Forecast - 30 Days FREE Trial $78701M -40.1x 5.9x
MTSI Unlock Forecast - 30 Days FREE Trial $11271M 139.1x 8.9x
MU Unlock Forecast - 30 Days FREE Trial $254279M 27.2x 4.7x
MX Unlock Forecast - 30 Days FREE Trial $110M -3.9x 0.4x
MXL Unlock Forecast - 30 Days FREE Trial $1333M -4.6x 2.9x
NA Unlock Forecast - 30 Days FREE Trial $83M x 0.1x
NLST Unlock Forecast - 30 Days FREE Trial $189M -3.3x -3.3x
NVDA Unlock Forecast - 30 Days FREE Trial $5087180M 52.9x 50.8x
NVEC Unlock Forecast - 30 Days FREE Trial $348M 25.5x 5.8x
NVTS Unlock Forecast - 30 Days FREE Trial $2625M -15.1x 6.9x
NXPI Unlock Forecast - 30 Days FREE Trial $52078M 26.2x 5.2x
ON Unlock Forecast - 30 Days FREE Trial $21136M 45.7x 2.7x
OSIS Unlock Forecast - 30 Days FREE Trial $4188M 25.6x 4.4x
PENG Unlock Forecast - 30 Days FREE Trial $1181M 46.5x 3.0x
PLAB Unlock Forecast - 30 Days FREE Trial $1388M 12.7x 1.2x
POWI Unlock Forecast - 30 Days FREE Trial $2330M 71.9x 3.3x
PRSO Unlock Forecast - 30 Days FREE Trial $0M -0.1x 0.0x
PXLW Unlock Forecast - 30 Days FREE Trial $39M -1.7x -18.9x
QRVO Unlock Forecast - 30 Days FREE Trial $8860M 105.9x 2.6x
QUIK Unlock Forecast - 30 Days FREE Trial $110M -651.3x 4.0x
RBCN Unlock Forecast - 30 Days FREE Trial $10M 11.2x 3.3x
RMBS Unlock Forecast - 30 Days FREE Trial $11988M 50.5x 9.3x
SEDG Unlock Forecast - 30 Days FREE Trial $2147M -0.9x 4.2x
SEVCF Unlock Forecast - 30 Days FREE Trial $103M x x
SHLS Unlock Forecast - 30 Days FREE Trial $1736M 85.1x 3.0x
SITM Unlock Forecast - 30 Days FREE Trial $7219M -44.5x 6.6x
SKYT Unlock Forecast - 30 Days FREE Trial $783M -20.5x 17.3x
SLAB Unlock Forecast - 30 Days FREE Trial $4342M -18.2x 4.1x
SMTC Unlock Forecast - 30 Days FREE Trial $6036M 237.1x 10.6x
SMTK Unlock Forecast - 30 Days FREE Trial $9M x 1.3x
SPCB Unlock Forecast - 30 Days FREE Trial $41M -0.9x 1.1x
STM Unlock Forecast - 30 Days FREE Trial $22167M x 1.3x
STMEF Unlock Forecast - 30 Days FREE Trial $25625M x 1.5x
SYNA Unlock Forecast - 30 Days FREE Trial $2705M 15.9x 1.9x
TE Unlock Forecast - 30 Days FREE Trial $561M x 3.0x
TSEM Unlock Forecast - 30 Days FREE Trial $9314M x 3.5x
TXN Unlock Forecast - 30 Days FREE Trial $146478M 31.2x 8.8x
TYGO Unlock Forecast - 30 Days FREE Trial $160M -0.9x 94.8x
UCTT Unlock Forecast - 30 Days FREE Trial $1269M -331.9x 1.8x
VIAV Unlock Forecast - 30 Days FREE Trial $3118M 88.1x 4.0x
VLN Unlock Forecast - 30 Days FREE Trial $181M x 1.6x
WOLF Unlock Forecast - 30 Days FREE Trial $4825M -1.3x 1.0x

Frequently Asked Questions - NVE CORP /NEW/ Stock Forecast

How accurate are NVE CORP /NEW/ stock predictions?

Our AI model shows a 12% Spearman correlation coefficient for NVEC predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence NVE CORP /NEW/ stock price forecasts?

Our analysis considers NVE CORP /NEW/'s financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is NVE CORP /NEW/ a good investment in 2025?

Based on our AI analysis, NVE CORP /NEW/ shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are NVE CORP /NEW/ forecasts updated?

NVE CORP /NEW/ stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced NVE CORP /NEW/ Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for NVE CORP /NEW/ stock.

My Portfolio

Investment Dashboard

Loading your portfolio...